by Viara Staneva | Feb 24, 2020 | news
After years of opioid litigation and a multibillion-dollar settlement offer from the nation’s top drug distributors, nearly two dozen U.S. states have rejected their proposal, The Wall Street Journal reports. Twenty-one state attorneys general sent a letter to...
by Viara Staneva | Feb 18, 2020 | news
Drug pricing remains a hot topic, and a new report offers some reasons: The most expensive drugs sold at pharmacies can cost as much as a luxury car—every month. And GoodRx’s latest ranking of the country’s costliest drugs include brands new and old....
by Viara Staneva | Sep 25, 2019 | news
French pharma Servier begins trial today, as the company stands accused of manslaughter and deceit over a diabetes weight loss drug linked to as many as 2,000 deaths. The drug, Mediator (benfluorex), was pulled out of French pharmacies in 2009 after 33 years on the...
by Viara Staneva | Jul 19, 2019 | news
Тhe BACE theory of controlling Alzheimer’s died with failed pivotal projects at Merck, Eli Lilly and their partners at AstraZeneca. Now Amgen and Novartis have come along to bulldoze it under a mound of safety threats — leaving only Biogen and Eisai to carry on with a...
by admin | Jul 15, 2019 | news
When a new drug is approved, the developer usually trumpets its ability to fill an unmet medical need. But a German agency that evaluates the quality of medical treatments disagrees is calling for an international reform of drug development and approval. In...
by admin | Jun 26, 2019 | news
Cancer is probably the most sought-after indication in the biopharma world, but it’s missing from 2019’s class of top drug launches. Instead, treatments in immunology and rare genetic diseases have grabbed the limelight. We considered two EvaluatePharma...
